Navigation Links
The Female Health Company Switches to the NASDAQ Stock Market

CHICAGO, May 29 /PRNewswire-FirstCall/ -- The Female Health Company (NYSE Amex: FHC) announced today that its Board of Directors has approved the decision to switch the listing of its common stock from the NYSE AMEX LLC to the NASDAQ Stock Market LLC. Effective as of the opening of trading on Tuesday, June 9, 2009 the Company's shares will commence trading on NASDAQ under the symbol [FHCO].

"This decision was reached after careful consideration of capital market alternatives and analysis of the electronic market model, which provides added visibility to our investors," said O.B. Parrish, Chairman and C.E.O. of The Female Health Company. "We believe that NASDAQ's electronic multiple market maker structure will provide our company with enhanced exposure and liquidity, while at the same time providing investors with the best prices, the fasted execution, and the lowest cost per trade. As the world's largest electronic stock market, NASDAQ promotes innovation and attracts leading growth companies from a diverse group of sectors. We are proud to be a part of the NASDAQ Stock Market."

NASDAQ is the largest U.S. electronic stock market. With approximately 3,200 companies, it lists more companies and, on average, its systems trade more shares across all areas of business including technology, retail, communications, financial services, transportation, media and biotechnology. NASDAQ is the primary market for trading NASDAQ-listed stocks. For more information about NASDAQ, visit the NASDAQ website at or the NASDAQ Newsroom

About The Female Health Company

The Female Health Company (FHC), headquartered in Chicago, IL, is the maker of the FC Female Condom (FC1 and FC2), a revolutionary option offering women dual protection against both sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. FHC was created as a worldwide company in February 1996 with the purchase of Chartex Resources Ltd., the holder of exclusive worldwide rights to FC1. The Company holds exclusive product and technology patents for FC1 in the United States, Australia, Brazil, Canada, France, Germany, Italy, Spain, the United Kingdom, the People's Republic of China, South Korea and Japan. FC2 patents have been granted in Australia and South Africa and are pending in various other countries. FHC is the sole manufacturer and marketer of the FC1 and FC2 female condoms in the world. The Female Health Company and its partners currently market the Female Condom under FC Female Condom(R), FC2 Female Condom(R), Reality(R), Femidom(R), Femy(R), and Care(R).

"Safe Harbor" statement under the Private Securities Litigation Reform Action of 1995: The statements in this release which are not historical facts are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchange Commission filings. Actual events affecting the Company and the impact of such events on the Company's operations may vary from those currently anticipated.

For more information about the Female Health Company visit the Company's web site at and

If you would like to be added to an e-mail alert list, please send an e-mail to

SOURCE The Female Health Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Females avoid incest by causing male relatives to leave home
2. Gene Studies of Male-Female Differences Often Flawed
3. Struggling male readers respond better to female teachers
4. More sick leave given to men by male GPs compared with female counterparts
5. Researchers discover correlation between GERD and obesity in females
6. Most patients who have male-to-female sex-change surgery are happy, despite complications
7. Galderma Associates Itself to Cartiers Womens Initiative Awards to Recognize Female Entrepreneurs From Around the Globe
8. Do Not Take the Pill! Dr. Prudence Hall Tells her Teen and Female Patients
9. Female Blood Donor Concern May Be Unfounded
10. Some Female Athletes Risking Weaker Bones
11. The Female Health Company Schedules Fiscal Year End Conference Call for Monday, November 26, 2007
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... Altec Products, ... Title Sponsorship of Synergy 2015. The annual WennSoft KEY2ACT user conference will take ... and will unite customers, partners, WennSoft team members and sponsors to facilitate the ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... County, Illinois with more than 59,000 emergency department visits per year, today announced ... from T-System, to help improve clinical, operational and financial outcomes. , ...
(Date:10/13/2015)... ... 2015 , ... California Southern University has named Dr. Judith ... Doctor of Nursing Practice from the renowned Johns Hopkins University—comes to CalSouthern with ... McLeod’s long and successful nursing practice included a variety of patient care, education ...
(Date:10/13/2015)... CA (PRWEB) , ... October 13, 2015 , ... According ... Derrick Rose suffered an orbital fracture when a teammate accidentally elbowed him in the ... 2015. Rose's recent eye injury is just one of a series of setbacks, including ...
(Date:10/13/2015)... ... ... With Fall weather approaching and holiday travel season upon us, is giving away ... to win! , How to Enter:, 1. Like on Facebook , 2. ... us on Instagram @thebeautyplace , 4. Share Facebook Contest Image With Friends , ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... Research and Markets ( ) has announced the ... Yeast, Mold, Others), Flavors (Herbs & Spices, Citrus, Berries, ... - Forecasts to 2020" report to their offering. ... --> The global market for kombucha has grown ... value, the market is projected to reach USD 1.8 ...
(Date:10/13/2015)... WuXi PharmaTech (Cayman) Inc. (NYSE:  WX), a ... serving the pharmaceutical, biotechnology, and medical device industries, ... version of OncoWuXi, the first App in the ... and data on the go.  The OncoWuXi App ... to identify relevant tumor models for use in ...
(Date:10/13/2015)... , Oct. 13, 2015  The ... Harvard University today announced the launch of ... Ultivue will introduce imaging reagents providing ... to those of expensive specialized instruments. The ... Harvard,s Office of Technology Development (OTD) ...
Breaking Medicine Technology: